A pre-mixed three-peptide blend (GHK-Cu, TB-500, BPC-157) studied for skin elasticity, collagen synthesis, and tissue regeneration.
GLOW reconstitutes to a set concentration. Add 3.5 mL of bacteriostatic water to a 50 mg vial for a 14.29 mg/mL solution.
| Vial size | BAC water | Concentration | 3.5 mg draws to |
|---|---|---|---|
| 50 mg | 3.5 mL | 14.29 mg/mL | 24.5 units |
| 70 mg | 5 mL | 14 mg/mL | 25 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 3.5 mg. At 14.29 mg/mL, that draws to 24.5 units on a U-100 insulin syringe.
GHK-Cu signals collagen synthesis at the gene level while TB-500 drives cell migration and vascular repair and BPC-157 amplifies soft-tissue healing. The three act across complementary repair pathways.
GLOW is commonly taken morning and evening.
Add 3.5 mL of bacteriostatic water to a 50 mg GLOW vial for a 14.29 mg/mL solution.
A common GLOW starting dose is 3.5 mg, which at 14.29 mg/mL draws to 24.5 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the GLOW vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.